APA (7th ed.) Citation

Hongmei Cui, Hongmei Cui, Qinghui Wang, Duane D. Miller, & Wei Li. (2021). The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Hongmei Cui, Hongmei Cui, Qinghui Wang, Duane D. Miller, and Wei Li. The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Hongmei Cui, et al. The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma. Frontiers Media S.A., 2021.